Short answer: New Jersey’s medicinal cannabis program works from a list of named qualifying conditions. The list is defined in N.J.S.A. 24:6I-3 statute text, and the New Jersey Cannabis Regulatory Commission publishes the list on its medicinal cannabis page. It is built two ways: named conditions, and a closing clause in the statute covering “any other medical condition or its treatment that is approved by the commission.”
Being on the list is one requirement for access, not proof that cannabis helps with that condition. The most recent decision on the list covered here is the revised decision of January 23, 2019. To see whether the list has changed since, check the Commission’s page for its current update date. For the application steps, fees and forms, see our New Jersey medical marijuana card guide. This page covers the list.

Which conditions qualify for medical marijuana in New Jersey?
The Commission’s main medicinal cannabis page, which carries the “Do I Qualify” section, lists 18 conditions. Its patient FAQ and health care provider page list 17 of them; the difference is sickle cell anemia. The table keeps each Commission wording as printed, and sets the statute’s wording beside it so you can compare them. The middle column is the statute.
| Commission wording | Statute wording (N.J.S.A. 24:6I-3) | Where the Commission lists it |
|---|---|---|
| Amyotrophic lateral sclerosis | amyotrophic lateral sclerosis | All three Commission pages |
| Anxiety | anxiety | All three Commission pages |
| Cancer | cancer | All three Commission pages |
| Chronic pain | chronic pain | All three Commission pages (the 2019 decision’s wording is covered below) |
| Dysmenorrhea | dysmenorrhea | All three Commission pages |
| Glaucoma | glaucoma | All three Commission pages |
| Inflammatory bowel disease, including Crohn’s disease | inflammatory bowel disease, including Crohn’s disease | All three Commission pages |
| Intractable skeletal muscular spasticity | intractable skeletal muscular spasticity | All three Commission pages |
| Migraine | migraine | All three Commission pages |
| Multiple sclerosis | multiple sclerosis | All three Commission pages |
| Muscular dystrophy | muscular dystrophy | All three Commission pages |
| Opioid Use Disorder | opioid use disorder | All three Commission pages |
| Positive status for Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) | positive status for human immunodeficiency virus; acquired immune deficiency syndrome | All three Commission pages |
| Post-Traumatic Stress Disorder (PTSD) | post-traumatic stress disorder | All three Commission pages |
| Seizure disorder, including epilepsy | seizure disorder, including epilepsy | All three Commission pages |
| Sickle cell anemia | Not in the statute text | Main page only |
| Terminal illness with prognosis of less than 12 months to live | terminal illness, if the patient has a prognosis of less than 12 months of life | All three Commission pages |
| Tourette Syndrome | Tourettes syndrome | All three Commission pages |
| Not named on the lists | or any other medical condition or its treatment that is approved by the commission | Covered by the statute’s closing words |
MedlinePlus says the conditions marijuana can be used to treat vary from state to state, and that the FDA has not approved marijuana for treating any health conditions (MedlinePlus’s medical marijuana page). If you are comparing states, our state medical cannabis card programs compared hub explains how the programs differ.
Where the lists and the statute word things differently
Sickle cell anemia. The Commission’s main page lists it. Its patient FAQ and provider page do not, and the statute text does not either. Confirm with the Commission before you rely on it.
Opioid use disorder. The Commission’s patient FAQ says, “Opioid use disorder patients may be eligible for medical cannabis to treat the opioid disorder itself, or if they suffer from chronic, painful withdrawal symptoms.” The January 23, 2019 decision from the Department of Health, which is the decision letter’s own header, describes eligibility as chronic, painful withdrawal symptoms or as an adjunct to current medication-assisted treatment. It makes the approval conditional on medical marijuana being prescribed together with medication-assisted therapy for the disorder.
Chronic pain. The Commission’s lists and the statute say “chronic pain” with no further qualifier. The January 23, 2019 decision describes the chronic pain addition as chronic pain associated with musculoskeletal disorders and chronic pain of a visceral origin.
What to tell your doctor to get a medical card
Tell the clinician which listed condition you have, and be ready to describe how long they have treated you. The Commission’s “Do I Qualify” section says the practitioner-patient relationship must meet one of three tests: it has lasted at least one year; the provider has seen and assessed you for the condition on at least four visits; or the provider has taken on your condition’s care after a full medical history and physical exam, including a review of your records from other treating doctors that shows how you responded to conventional treatments.
On the state’s own terms, you must be a New Jersey resident and have the condition diagnosed by a New Jersey healthcare practitioner registered with the program. The full application steps are in our New Jersey medical marijuana card guide.
Is a medical card worth it, and how hard is it to get one in NJ?
Whether a card is worth it depends on your condition, your care and what you need from the program, and that decision is yours. Before you can start, the Commission’s Do I Qualify section sets out the residency, diagnosis and provider requirements covered above. If you do not yet have a provider who meets one of the three relationship tests, that is the step to plan for first.
What if my condition is not on the list?
The statute’s closing words, “any other medical condition or its treatment that is approved by the commission,” are the route for conditions that are not named. The Commission’s Review Panel page says the Medicinal Cannabis Review Panel reviews petitions to add debilitating medical conditions to the list, and that its recommendations to approve or deny go to the Commission.
How a condition gets added, and who decides
The January 23, 2019 decision, which is the revised decision letter, describes the 2016 petition round this way:
- The Department published a request for petitions in the New Jersey Register on July 5, 2016, and accepted petitions from August 1 to August 31, 2016.
- It received sixty-eight petitions. Twenty-three were turned away for missing required information, and forty-five were accepted for consideration. The required information is set out in N.J.A.C. 8:64-5.3.
- Petitions were judged on six factors: how generally accepted the condition is as a valid medical condition; whether the treatments that cause suffering are generally accepted; how severely the condition or its treatment causes suffering; whether conventional therapies are available that do not cause that suffering; whether generally accepted evidence supports that marijuana relieves the suffering; and whether letters of support came from physicians or other licensed health professionals.
The Review Panel makes recommendations, and the Commission decides, as the Review Panel page states.
What changed, and when
- March 22, 2018: The final agency decision added chronic pain related to a musculoskeletal disorder. Opioid use disorder was included in that chronic pain category.
- Post-traumatic stress disorder: According to the 2019 decision, legislation enacted while petitions were pending added it to the list.
- January 23, 2019: The revised final agency decision replaced the March 22, 2018 decision. It added chronic pain associated with musculoskeletal disorders, chronic pain of a visceral origin, Tourette’s Syndrome, migraine, anxiety, and opioid use disorder as a standalone condition, with the medication-assisted therapy condition.
The same January 23, 2019 decision denied two petitions:
- Asthma. The decision accepts that asthma is a recognized medical condition. It found that the treatments the petitioner cited, albuterol and corticosteroids, are generally accepted treatments, and that the average patient does not suffer from them in the way the petition described. It concluded asthma does not meet the requirements for inclusion.
- Chronic fatigue syndrome. The decision found the condition can be debilitating for some patients, but concluded that medical marijuana is not likely to be a beneficial treatment for its debilitating effects or symptoms. It cited a lack of support from physicians or other health professionals, and no clinical evidence that marijuana would be beneficial. It decided not to add the condition for now.
These are decisions on those two petitions, not a ruling that either condition can never qualify.
What to confirm with the Commission
This page covers the qualifying list. Possession limits, recreational dispensary rules, cash-only payment, walk-in access and whether police can see a card are not part of that list, so ask the Commission directly through its medicinal cannabis page. Before you apply:
- Whether sickle cell anemia is on the list, since it appears on the main page but not on the patient FAQ, provider page or in the statute text.
- Whether the list has changed since January 23, 2019, and the current update date.
- Whether a condition you have that is not on the list can go through the petition process described on the Review Panel page.
- The current possession, purchase and dispensary rules, which the qualifying list does not set.
HealthDataConsortium.org is a publisher, not a clinic and not a government office.
By HealthDataConsortium.org Research Team
This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.

